$MRNA 0.46 Noisy

Notable posts

• @StockSavvyShay neutral 664 eng

  NEXT WEEKS EARNINGS ARE MASSIVE • Monday | $APLD, $NVTS, $CDNS, $AMKR • Tuesday | $BE, $KLAC, $PYPL, $V, $TER, $ENPH • Wednesday | $MSFT, $META, $HOOD, $ARM, $QCOM, $SOFI, $VRT, $LMND, $LRCX, $VKTX, $FTNT, $CVNA • Thursday | $AAPL, $AMZN, $COIN, $RBLX, $RDDT, $TEM, $RIVN, $FSLR, $MA, $PGY, $MSTR, $AXTI, $NXT • FRIDAY | $CVX, $XOM, $ABBV, $CCJ, $MRNA

  view on X →
• @Mr_Derivatives bullish 330 eng

  Weird to say but this Covid name is now trading at a fresh near two year high today and is up 160% ytd already. Making it the 8th best performing S&P500 component edging out even the likes of AMD. That name is, you guessed it, $MRNA.

  view on X →
• @wallstengine neutral 39 eng

  MODERNA $MRNA Q2’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $145M (Est. $103M) 🟢; +2% YoY 🔹 EPS: -$1.97 (Est. -$2.08) 🟢 🔹 Net Loss: -$0.8B; 5% improvement YoY 🔸 mRNA-1403: Missed Phase 3 Early Success Bar FY26 Guide: 🔹 Revenue: Up to 10% growth 🔹 Cost of Sales: ~$1.7B; lowered from ~$1.8B 🔹 R&D Expense: ~$2.9B; lowered from ~$3.0B 🔹 SG&A Expense: ~$1.0B 🔹 CapEx: $0.2B-$0.3B (Est. $259M) 🟡 🔹 Cash & Investments (YE): $4.7B-$5.2B; +~$0.2B Comments: 🔸 “In the second half of 2026, we are preparing for the potential approval of mFLUSIVA in the U.S., which would be our fifth approved product, and continue to anticipate important pivotal readouts for our intismeran in melanoma and propionic acidemia programs.” 🔸 “The second quarter marked another period of strong execution for Moderna as we advanced our pipeline and strengthened our financial profile with an improved 2026 operating expense outlook.”

  view on X →
• @tenet_research neutral 26 eng

  Tenet Market Wake-Up Summary 📷📷 July.31.26 $SMCI $NVDA $RKLB $RDW $FLY $LHX $VSAT $AAPL $AVGO $TSLA $SPCX $AMZN $NVDA $NVO $CRCL $SKHY $AMD $INTC $NVDA $BABA $MSFT $TEM $FSLR $NXT $MSTR $GDDY $LEA $LIN $AU $CVX $MTD $MRNA $EXPO $SYK $EIX $DXC $WY $CRCL $PTEN $COIN $META $BIRK $AMZN $GDDY $EIX $RBLX $REPL $AXTI $KPTI $MYGN @ripster47 | @TENETTRADEGROUP | @TenetCharts

  view on X →